New hope for lung cancer patients after First-Line treatment fails
NCT ID NCT06382116
Summary
This study is testing a new drug called BL-B01D1 against standard chemotherapy for people with advanced non-small cell lung cancer. It's for patients whose cancer has continued to grow despite treatment with EGFR-targeted drugs. The goal is to see if the new drug can better control the cancer and extend the time patients live without their disease getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.